Hormonal therapy for prostate cancer can be rough with unpleasant side effects. Johns Hopkins provides advice to help soften the impact. The male hormone testosterone influences more than a man's sex life. It also plays a role in bone health, muscle mass, levels of energy, and even psychological well-being. Hormonal therapies for prostate cancer, known as androgen-deprivation therapy, shut down testosterone production. When testosterone levels plummet, the effects are swift and unpleasant. Knowing what side effects… More...
Investigational new treatments to relieve symptoms of enlarged prostate, BPH, include aspirin, Viagra, Botox, and a number of promising new drugs.
Current medical treatment for benign prostatic hyperplasia (BPH, or an enlarged prostate) relies on alpha-1-adrenergic blockers (alpha-blockers), which relax muscles in the prostate, or 5-alpha-reductase inhibitors, which lower androgen levels within the prostate. … More...
Widespread yearly screening with the prostate-specific antigen (PSA) test has done a good job of detecting prostate cancer before it has spread. Thanks to PSA testing, many men today who are diagnosed with prostate cancer have early-stage disease that can be managed effectively with either radical prostatectomy or radiation treatment. More...
Determining a course of treatment for prostate cancer is one of the most harrowing decisions in modern medicine. Not only do treatments such as surgery and radiation therapy have troubling side effects, but doctors can’t agree on which treatments work best—and are more likely to recommend the option that they specialize in. Hence, to be in the best position for making decisions about your own treatment for prostate cancer, it’s vital to get more than one opinion.
More...
The PSA test, first approved by the FDA in 1986 as a way to monitor treatment of prostate cancer, is now widely used as a tool to screen for the presence of prostate cancer. Thousands of men, including public figures, have had their prostate cancer diagnosed with the help of this test (which measures prostate-specific antigen, a protein produced in the prostate and released into the blood). But the use of PSA testing has also been accompanied by controversy. More...
Nearly all of the treatments for benign prostatic hyperplasia (BPH) and prostate cancer
have the potential to cause sexual problems. For instance, surgery and radiation therapy can result in erectile dysfunction, and BPH medications and hormone therapy can produce both erectile dysfunction and reduced sex drive. Even the anxiety and stress
More...
Transurethral prostatectomy (TURP) is the gold standard treatment for BPH (benign prostatic hyperplasia), but in recent years, clinicians have developed and refined a number of minimally invasive alternatives for those patients with prostate disease.
Two such treatments for BPH—transurethral needle ablation (TUNA) and transurethral microwave thermotherapy (TUMT)—have become increasingly popular among prostate patients because of their ability to relieve symptoms of BPH while producing fewer
More...
The Johns Hopkins Prostate Bulletin The Johns Hopkins Prostate Bulletin is a quarterly publication that presents the latest treatment information available on prostate cancer, enlarged prostate (BPH), and prostatitis to help you take charge of your medical care for prostate disease. Each issue is like having an in-depth consultation with a leading specialist. PLUS, subscribe now and get a special discount PLUS 5 FREE Special Reports as INSTANT PDF DOWNLOADS:
Special Report #1: BPH (Benign Prostatic Hyperplasia)
Special Report #2: Diet and Prostate Health
Special Report #3: Treating Overactive Bladder
Special Report #4: Chronic Prostatitis: New Research, Renewed Hope—
A series of cutting-edge publications designed to address your specific prostate questions.
ChoosingThe Right Treatment For Your Prostate Cancer You have hundreds of questions about your prostate cancer. America's #1 Urology Center's specialists have the answers.ChoosingThe Right Treatment For Your Prostate Cancer is a detailed, up-to-the-minute treatment guide so you can know all your optionsbefore making any irrevocable decisions about your prostate cancer treatment.Read more...
JohnsHopkins Prostate Bulletin: Prostate Cancer Review 2007 Where we've been, where we are, and where we're going in the world of prostate cancer diagnosis and effective prostate cancer treatment.Readmore....
JohnsHopkins Prostate Bulletin: The Radical Prostatectomy, by Dr. Patrick Walsh; Rare and Unusual Cancers of theProstate On the 25th anniversary of his first performing a radical prosatectomy, Dr. Patrick Walsh brings you up to date on what you need to know about this procedure, and how to choose the best surgeon for YOU. Plus, the prostate can be affected by other forms of cancer than prostate cancer. Could your doctor be missing something?Readmore...
JohnsHopkins Prostate Bulletin: The Future of Prostate Surgical Technology; The AUA PSA Testing Debate The latest information on emerging technologies to treat prostate cancer, including robotic radical prostatectomy, and HIFU. Plus, learn more about the ongoing debate concerning the benefits versus drawbacks of PSA Testing for older men, straight from the American Urological Association Conference Debate.Readmore...
ALL NEW!
Johns Hopkins has been ranked #1 again in the Honor Roll of America's Best Hospitals by U.S. News and World Report for the 17th consecutive year.
Medical Disclaimer: The information on this page is not intended to substitute for the advice of a physician.
Charter Subscription to The Johns Hopkins Prostate Bulletin
PLUS 5 FREE Special Reports, available right now as INSTANT PDF DOWNLOADS
The Johns Hopkins Prostate Bulletin brings you up-to-the-minute information about the latest advances in prostate medicine, from the very experts at the forefront of life-saving discoveries in this vital field. From prostate cancer, and prostate surgery and common side effects such as erectile dysfunction and incontinence, to prostatitis, to Benign Prostatic Hyperplasia (BPH) to Prostate Cancer, The Johns Hopkins Prostate Bulletin provides the most cutting–edge information for men (and their loved ones!) facing these health challenges. It's like having an in-depth consultation from a specialist from America's #1 medical center.
ADDED BONUS: FREE SPECIAL REPORTS!
What you will get with your subscription to The Johns Hopkins Prostate Bulletin. In every issue of your Johns Hopkins Prostate Bulletin, you'll receive:
Quarterly briefings on the latest medical developments
Late breaking news of innovative new treatments and essential health study results
Expert evaluations and comparisons of new medications, surgical techniques, and diagnostic procedures
Authoritative medical guidance from leading experts around the world
At least one in-depth Special Report or update on the most important breakthroughs in prostate cancer, BPH, ED, LUTS, or prostatitis.
Answers to your most pressing questions about your prostate disorders in the Grand Rounds section
ALL delivered direct to you via Priority Mail!
As soon as you place your order, you will also receive your five FREE Prostate Disorders Special Reports as INSTANT PDF DOWNLOADS, so you can start using the information you learn right away in your quest for answers about your medical condition and how best to treat it. * Prostate Bulletin Special Report #1: BPH (Benign Prostatic Hyperplasia) * Prostate Bulletin Special Report #2: Diet and Prostate Health * Prostate Bulletin Special Report #3: Treating Overactive Bladder * Prostate Bulletin Special Report #4: Chronic Prostatitis: New Research, Renewed Hope * Prostate Bulletin Special Report #5: The Radical Prostatectomy
Your risk-FREE subscription and 100% money-back guarantee. The Johns Hopkins Prostate Bulletin is yours to review risk-FREE. If you are not completely satisfied, simply return the Bulletin and receive a refund with no questions asked. Keep the five Prostate Disorders Special Reports just for reviewing the Bulletin.
Only by private subscription. Don't bother looking for The Johns Hopkins Prostate Bulletin on the newsstand. It is available only by private subscription, delivered directly to you quarterly via Priority Mail.
